Copyright
©The Author(s) 2020.
World J Diabetes. Nov 15, 2020; 11(11): 489-500
Published online Nov 15, 2020. doi: 10.4239/wjd.v11.i11.489
Published online Nov 15, 2020. doi: 10.4239/wjd.v11.i11.489
OR | 95%CI | P value | ||
Model 1 | ||||
TIR | -0.021 | 0.979 | 0.971-0.987 | < 0.001 |
Age | 0.023 | 1.024 | 1.003-1.045 | 0.027 |
Smoking | 0.632 | 1.881 | 1.115-3.174 | 0.018 |
Model 2 | ||||
TIR | -0.024 | 0.976 | 0.967-0.986 | < 0.001 |
Age | 0.024 | 1.024 | 1.003-1.045 | 0.027 |
Smoking | 0.632 | 1.881 | 1.113-3.177 | 0.018 |
Model 3 | ||||
TIR | -0.025 | 0.975 | 0.957-0.994 | 0.010 |
Age | 0.031 | 1.031 | 1.008-1.055 | 0.008 |
Smoking | 0.717 | 2.047 | 1.146-3.659 | 0.016 |
M value | 0.093 | 1.097 | 1.040-1.158 | 0.001 |
- Citation: Guo QY, Lu B, Guo ZH, Feng ZQ, Yuan YY, Jin XG, Zang P, Gu P, Shao JQ. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes. World J Diabetes 2020; 11(11): 489-500
- URL: https://www.wjgnet.com/1948-9358/full/v11/i11/489.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i11.489